|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
|
US6113940A
(en)
|
1997-03-03 |
2000-09-05 |
Brooke; Lawrence L. |
Cannabinoid patch and method for cannabis transdermal delivery
|
|
US6328992B1
(en)
|
1997-03-03 |
2001-12-11 |
Lawrence L. Brooke |
Cannabinoid patch and method for cannabis transdermal delivery
|
|
JP2003504321A
(ja)
|
1999-07-08 |
2003-02-04 |
オーランド・ハン |
リポソーム被包カンナビノイドの肺送達
|
|
US20050042271A1
(en)
|
1999-11-19 |
2005-02-24 |
Xel Herbaceuticals, Inc . |
Transdermal delivery system for alkaloids of aconitum species
|
|
WO2001064149A1
(en)
|
2000-02-29 |
2001-09-07 |
Jie Zhang |
Improved transdermal drug patch
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
NZ524940A
(en)
*
|
2000-11-06 |
2003-08-29 |
Samyang Corp |
A multilayered sandwich transdermal drug delivery system with improved water absorbability and adhesion properties
|
|
US8449908B2
(en)
|
2000-12-22 |
2013-05-28 |
Alltranz, Llc |
Transdermal delivery of cannabidiol
|
|
DK1361864T3
(en)
|
2001-02-14 |
2014-03-03 |
Gw Pharma Ltd |
FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
|
|
US20180042842A1
(en)
|
2001-02-14 |
2018-02-15 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
US7025992B2
(en)
|
2001-02-14 |
2006-04-11 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
CH695661A5
(de)
|
2001-03-06 |
2006-07-31 |
Forsch Hiscia Ver Fuer Krebsfo |
Pharmazeutische Zusammensetzung.
|
|
GB2377218A
(en)
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
|
FI113340B
(fi)
|
2002-02-20 |
2004-04-15 |
Tomi Jaervinen |
Uudet luonnon syklodekstriinin kompleksit
|
|
DE10226494A1
(de)
|
2002-06-14 |
2004-01-08 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
|
|
US6946150B2
(en)
|
2002-08-14 |
2005-09-20 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
US10538373B2
(en)
|
2002-08-14 |
2020-01-21 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
ATE533472T1
(de)
|
2002-08-14 |
2011-12-15 |
Gw Pharma Ltd |
Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute
|
|
GB2394894B
(en)
|
2002-11-04 |
2005-08-31 |
G W Pharma Ltd |
New use for pharmaceutical composition
|
|
WO2004100893A2
(en)
|
2003-05-12 |
2004-11-25 |
Indevus Pharmaceuticals, Inc. |
Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
|
|
EP1559423A1
(en)
|
2004-02-02 |
2005-08-03 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
Medicinal acidic cannabinoids
|
|
IL160420A0
(en)
|
2004-02-16 |
2004-07-25 |
Yissum Res Dev Co |
Treating or preventing diabetes with cannabidiol
|
|
GB2414933B
(en)
|
2004-06-08 |
2009-07-15 |
Gw Pharma Ltd |
Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
|
|
US7671052B2
(en)
|
2004-10-05 |
2010-03-02 |
Adolor Corporation |
Phenyl derivatives and methods of use
|
|
WO2006044645A2
(en)
|
2004-10-13 |
2006-04-27 |
Adolor Corporation |
Sulfamoyl benzamides and methods of their use
|
|
US7968594B2
(en)
|
2005-04-27 |
2011-06-28 |
Gw Pharma Limited |
Pharmaceutical compositions for the treatment of pain
|
|
US20060263421A1
(en)
|
2005-05-18 |
2006-11-23 |
Abeille Pharmaceuticals Inc |
Transdermal Method and Patch for Nausea
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20070060638A1
(en)
|
2005-08-26 |
2007-03-15 |
Olmstead Mary C |
Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
|
|
GB2431105A
(en)
|
2005-10-12 |
2007-04-18 |
Gw Pharma Ltd |
Cannabinoids for the treatment of pulmonary disorders
|
|
GB2432312A
(en)
|
2005-11-01 |
2007-05-23 |
Gw Pharma Ltd |
Pharmaceutical compositions for the treatment of pain
|
|
US7544676B2
(en)
|
2005-11-10 |
2009-06-09 |
Adolor Corporation |
Sulfamoyl benzamides and methods of their use
|
|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
US8481085B2
(en)
|
2006-06-15 |
2013-07-09 |
Gw Pharma Limited |
Pharmaceutical compositions comprising cannabigerol
|
|
GB2439393B
(en)
|
2006-06-23 |
2011-05-11 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
US20100184848A1
(en)
|
2006-07-14 |
2010-07-22 |
William Abraham Wine |
Transdermal formulations of synthetic cannabinoids and nano colloidal silica
|
|
WO2008019146A2
(en)
|
2006-08-04 |
2008-02-14 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
WO2008021394A2
(en)
|
2006-08-15 |
2008-02-21 |
Theraquest Biosciences, Llc |
Pharmaceutical formulations of cannabinoids and method of use
|
|
WO2008024408A2
(en)
|
2006-08-22 |
2008-02-28 |
Theraquest Biosciences, Inc. |
Pharmaceutical formulations of cannabinoids for application to the skin and method of use
|
|
WO2008024490A2
(en)
|
2006-08-24 |
2008-02-28 |
Theraquest Biosciences, Inc. |
Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
|
|
EP2083825A4
(en)
|
2006-09-26 |
2009-11-04 |
Addiction Res Inst Inc |
HEPATITIS C TREATMENT COMPOSITIONS AND METHODS OF USING HEPATITIS C TREATMENT COMPOSITIONS
|
|
WO2008063625A2
(en)
|
2006-11-20 |
2008-05-29 |
Adolor Corporation |
Pyridine compounds and methods of their use
|
|
GB2448535A
(en)
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
GB2450741A
(en)
|
2007-07-05 |
2009-01-07 |
Gw Pharma Ltd |
Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
|
|
GB2450753B
(en)
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
DK2176208T3
(en)
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
JP2010535774A
(ja)
|
2007-08-06 |
2010-11-25 |
インシス セラピューティクス インコーポレイテッド |
経口カンナビノイド液体製剤および治療方法
|
|
GB2459637B
(en)
|
2008-01-21 |
2012-06-06 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
GB2471987B
(en)
|
2008-06-04 |
2012-02-22 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
EP2285362B1
(en)
|
2008-06-19 |
2017-08-09 |
LTS LOHMANN Therapie-Systeme AG |
Composition for transdermal delivery of cationic active agents
|
|
EP2363116A1
(en)
|
2008-06-25 |
2011-09-07 |
US Worldmeds LLC |
Sustained-release formulations comprising lofexidine for oral delivery
|
|
CA2760460C
(en)
*
|
2009-04-28 |
2019-04-02 |
Alltranz Inc. |
Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
|
|
EP2424568A1
(en)
|
2009-04-29 |
2012-03-07 |
University Of Kentucky Research Foundation |
Cannabinoid-containing compositions and methods for their use
|
|
PT2473475T
(pt)
|
2009-08-31 |
2017-08-02 |
Zynerba Pharmaceuticals Inc |
Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
|
|
CA2818813C
(en)
|
2010-11-23 |
2020-10-06 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of oral mucositis
|
|
JP5073124B2
(ja)
|
2010-12-07 |
2012-11-14 |
祐徳薬品工業株式会社 |
ノルアドレナリン作動性・特異的セロトニン作動性抗うつ薬含有経皮吸収型貼付製剤
|
|
US8642645B2
(en)
|
2011-05-20 |
2014-02-04 |
Brooks Kelly Research, LLC. |
Pharmaceutical composition comprising Cannabinoids
|
|
WO2013009928A1
(en)
|
2011-07-11 |
2013-01-17 |
Organic Medical Research |
Cannabinoid formulations
|
|
US20130022687A1
(en)
|
2011-07-19 |
2013-01-24 |
Fitzgerald Jr John James |
Topical transdermal method for delivering nutrients through the skin for expedited wound healing
|
|
GB2514054A
(en)
|
2011-09-29 |
2014-11-12 |
Gw Pharma Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB201117956D0
(en)
|
2011-10-18 |
2011-11-30 |
Otsuka Pharma Co Ltd |
Phytocannabinoids for use in the treatment of breast cancer
|
|
DK2804587T3
(da)
|
2012-01-19 |
2019-08-12 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
GB2515312A
(en)
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
US20150057342A1
(en)
|
2013-08-21 |
2015-02-26 |
Cannabics Pharmaceuticals Inc |
Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof
|
|
WO2015066302A2
(en)
|
2013-10-30 |
2015-05-07 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions, methods of use, and methods of treatment
|
|
US10064905B1
(en)
|
2013-11-11 |
2018-09-04 |
Ilysm, LLC |
Pharmaceutical preparation
|
|
US10555927B2
(en)
|
2013-11-11 |
2020-02-11 |
Ilysm, LLC |
Compositions and methods for enhancing sexual pleasure and performance
|
|
GB2524469A
(en)
|
2014-02-14 |
2015-09-30 |
Kind Consumer Ltd |
A cannabinoid inhaler and composition therefor
|
|
US9918961B2
(en)
|
2014-02-19 |
2018-03-20 |
Kind Consumer Limited |
Cannabinoid inhaler and composition therefor
|
|
US10653787B2
(en)
|
2014-03-18 |
2020-05-19 |
Izun Pharmaceuticals Corp |
Water-based cannabinoid and opioid compositions
|
|
US20160022627A2
(en)
|
2014-04-18 |
2016-01-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid patch
|
|
US11331279B2
(en)
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US20160271252A1
(en)
|
2014-05-29 |
2016-09-22 |
Insys Development Company, Inc. |
Stable cannabinoid formulations
|
|
EP4151234A1
(en)
|
2014-05-29 |
2023-03-22 |
Fresh Cut Development, LLC |
Stable cannabinoid formulations
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
AU2015279612A1
(en)
|
2014-06-27 |
2017-02-02 |
Kenton L. Crowley |
Buccal and sublingual cannabinoid formulations and method of making the same
|
|
GB2527590A
(en)
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
US11298477B2
(en)
|
2014-06-30 |
2022-04-12 |
Syqe Medical Ltd. |
Methods, devices and systems for pulmonary delivery of active agents
|
|
CN113616883B
(zh)
|
2014-06-30 |
2023-06-06 |
Syqe医药有限公司 |
向受试者肺部递送植物材料中的至少一药理活性剂的系统
|
|
US20160000843A1
(en)
|
2014-07-01 |
2016-01-07 |
MJAR Holdings, LLC |
High cannabidiol cannabis strains
|
|
US20160039591A1
(en)
|
2014-07-22 |
2016-02-11 |
Craig E. Kinzer |
Packaging systems, devices, methods, and composition including cannabinoid unit dose forms
|
|
AU2015308546A1
(en)
|
2014-08-25 |
2017-04-13 |
Clk Consult V/ Carsten Leonhard Knudsen |
Device with compositions for delivery to the lungs, the oral mucosa and the brain
|
|
CA2859930A1
(en)
|
2014-09-22 |
2016-03-22 |
Antony Paul Hornby |
A cannabis topical from heat treated cocount oil
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB201418713D0
(en)
|
2014-10-21 |
2014-12-03 |
Kymab Ltd |
Bindings Proteins
|
|
JP6676062B2
(ja)
|
2014-11-03 |
2020-04-08 |
ラモト アト テルーアビブ ユニバーシティー リミテッド |
認知低下を処置するための方法
|
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
|
WO2016092539A1
(en)
|
2014-12-07 |
2016-06-16 |
One World Cannabis Ltd |
Use of cannabis to treat migraine
|
|
WO2016103254A1
(en)
|
2014-12-21 |
2016-06-30 |
One World Cannabis Ltd |
Use of cannabis to treat psoriasis
|
|
WO2016109624A1
(en)
|
2014-12-30 |
2016-07-07 |
University Of Houston System |
Pharmaceutical compositions
|
|
US20160220593A1
(en)
|
2015-02-02 |
2016-08-04 |
Axim Biotechnologies, Inc. |
Cannabinoid and sugar alcohol complex, methods to make and use
|
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
|
HK1244715A1
(zh)
|
2015-03-02 |
2018-08-17 |
阿福金制药有限责任公司 |
用大麻素的局部区域神经影响性疗法
|
|
US20160338974A1
(en)
|
2015-03-02 |
2016-11-24 |
Afgin Pharma, Llc |
Topical regional neuro affective therapy with cannabinoid combination products
|
|
WO2016145193A1
(en)
|
2015-03-10 |
2016-09-15 |
Eleusis Benefit Corporation, Pbc |
Lsd for the treatment of alzheimer's disease
|
|
AU2016231788A1
(en)
|
2015-03-19 |
2017-10-12 |
One World Cannabis Ltd |
Preparations of cannabis emulsions and methods thereof
|
|
US9962340B2
(en)
|
2015-06-09 |
2018-05-08 |
Life Tech Global, Llc |
Device and method for the transdermal delivery of cannabidiol
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
JP6976242B2
(ja)
|
2015-07-22 |
2021-12-08 |
フィトファーマ インターナショナル リミテッドPhytopharma International Ltd. |
ハナバチ摂取組成物、ハチミツの製造におけるその使用方法、およびそれにより製造されたハチミツ
|
|
US9827282B2
(en)
|
2015-07-24 |
2017-11-28 |
Bao Tran |
Medication dispensing system
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
CA2995418A1
(en)
|
2015-08-11 |
2017-02-16 |
KannaInnovations LLC |
Topical compositions comprising hydroxy acids and cannabinoids for skin care
|
|
US10272125B2
(en)
*
|
2015-09-14 |
2019-04-30 |
Life Tech Global, Llc |
Transdermal delivery of cannabidiol with other active moieties including cannabinoids
|
|
CN108697665A
(zh)
|
2015-09-30 |
2018-10-23 |
乔治·爱德华·霍格 |
局部镇痛性疼痛缓解制剂、其制备和使用方法
|
|
US10695287B2
(en)
|
2015-11-17 |
2020-06-30 |
Cersci Therapeutics, Inc. |
AMPK agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same
|
|
US20170202895A1
(en)
|
2016-01-18 |
2017-07-20 |
Kevin Anthony Hugh |
Cannabis Pellets
|
|
US10338355B2
(en)
|
2016-02-05 |
2019-07-02 |
Largan Precision Co., Ltd. |
Lens assembly
|
|
PT3429580T
(pt)
|
2016-03-16 |
2025-08-12 |
Buzzelet Development And Technologies Ltd |
Composição de canabinoides enriquecida em terpenos
|
|
MX2018012448A
(es)
|
2016-04-12 |
2019-07-08 |
Habi Pharma Pty Ltd |
Preparacion liposomal y metodos de tratamiento.
|
|
LT6486B
(lt)
|
2016-04-13 |
2018-01-10 |
UAB "SatiMed" |
Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
|
|
CA3021144C
(en)
|
2016-04-19 |
2024-04-09 |
Canabuzz-Med |
Cannabis-enriched enzymatically treated therapeutic composition
|
|
BR112018071518A2
(pt)
|
2016-04-22 |
2019-02-19 |
Receptor Life Sciences, Inc. |
compostos medicinais à base de planta de ação rápida e suplementos nutricionais
|
|
GB2551985B
(en)
|
2016-07-01 |
2019-01-30 |
Gw Res Ltd |
Novel formulation
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
BR112018077541A2
(pt)
|
2016-07-11 |
2019-04-30 |
Intec Pharma Ltd. |
formulações orais gastrorretentivas e usos das mesmas
|
|
IL246790A0
(en)
|
2016-07-14 |
2016-09-29 |
Friedman Doron |
Self-dissolving compounds of cannabinoids
|
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
US10869842B1
(en)
|
2016-09-07 |
2020-12-22 |
David P Summers |
Transdermal delivery of pharmaceutical agents
|
|
US10098895B2
(en)
|
2016-09-07 |
2018-10-16 |
Glia, Llc |
Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves
|
|
US20200163931A1
(en)
|
2016-10-12 |
2020-05-28 |
Columbia Care Llc |
Oral composition of extracted cannabinoids and methods of use thereof
|
|
EP3534893A1
(en)
|
2016-11-02 |
2019-09-11 |
To Pharmaceuticals LLC |
Combination therapy of cbd and copaxone
|
|
WO2018083695A2
(en)
|
2016-11-02 |
2018-05-11 |
Tikun Olam Ltd |
Combination therapies
|
|
US20190255014A1
(en)
|
2016-11-07 |
2019-08-22 |
Avidas Pharmaceuticals Llc |
Therapeutic Cannabinoid Formulations and Methods for Their Use
|
|
EA201892396A1
(ru)
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
WO2018106108A1
(en)
|
2016-12-06 |
2018-06-14 |
KEPPEL HESSELING, Jan Marius |
Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
|
|
WO2018112138A1
(en)
|
2016-12-15 |
2018-06-21 |
Anavi Goffer Sharon |
Treatment of mental, movement and behavioral disorders
|
|
AU2017387141A1
(en)
|
2016-12-29 |
2019-07-18 |
Pure Ratios Holdings, Inc. |
Modular transdermal delivery system and associated methods of manufacture and use
|
|
US20180311181A1
(en)
|
2016-12-29 |
2018-11-01 |
International Bioceutical Co. LLC |
Modular Transdermal Delivery Systems for the Treatment of Insomnia and Anxiety
|
|
US20180311180A1
(en)
|
2016-12-29 |
2018-11-01 |
International Bioceutical Co. LLC |
Modular Transdermal Delivery Systems for the Treatment of Pain and Inflammation
|
|
NL2018190B1
(en)
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
WO2018148152A1
(en)
|
2017-02-07 |
2018-08-16 |
Wayne Green |
Terpene-based compositions, methods of preparations and uses thereof
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
US20180360757A1
(en)
|
2017-05-26 |
2018-12-20 |
Altum Pharmaceuticals Inc. |
Biphasix cannabinoid delivery
|
|
US10945967B2
(en)
|
2017-05-30 |
2021-03-16 |
Jae Wang. Song |
Formulations of a transdermal patch for pain management
|
|
WO2018222923A1
(en)
|
2017-05-31 |
2018-12-06 |
Phytecs, Inc. |
Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
|
|
US10668044B2
(en)
|
2017-06-27 |
2020-06-02 |
William H. Muscarella |
Blended cannabis compounds and methods of making the same
|
|
WO2019003163A2
(en)
|
2017-06-28 |
2019-01-03 |
Buzzelet Development And Technologies Ltd. |
CANNABINOID PRODUCT ENRICHED IN TERPENE GOOD FOR WOMEN'S HEALTH
|
|
US20190134121A1
(en)
|
2017-08-08 |
2019-05-09 |
Steven Bermudez |
Method for reduction, suppression, or elimination of anxiety or marijuana/cannabis effects and related marijuana/cannabis product by process
|
|
CA3071497A1
(en)
|
2017-08-13 |
2019-02-21 |
Buzzelet Development And Technologies Ltd |
Terpene-enriched cannabinoid composition and method of treatment
|
|
JP2020530857A
(ja)
|
2017-08-14 |
2020-10-29 |
ジナーバ・ファーマシューティカルズ・インコーポレイテッド |
経皮カンナビジオールゲルを用いた変形性関節症の治療方法
|
|
CA3079537A1
(en)
|
2017-09-02 |
2019-03-07 |
Scientific Holdings, Llc |
Tetrahydrocannabinol modulators
|
|
CN109498606A
(zh)
|
2017-09-15 |
2019-03-22 |
汉义生物科技（北京）有限公司 |
一种含有大麻二酚和/或次大麻二酚的组合物及其在治疗痛经中的应用
|
|
US20190083388A1
(en)
|
2017-09-19 |
2019-03-21 |
Zynerba Pharmaceuticals, Inc. |
Synthentic transdermal cannabidiol for the treatment of focal epilepsy in adults
|
|
US12357604B2
(en)
|
2017-09-22 |
2025-07-15 |
Inmed Pharmaceuticals Inc. |
Topical formulations of cannabinoids and use thereof in the treatment of pain
|
|
CA3300266A1
(en)
|
2017-09-28 |
2026-03-02 |
Harmony Biosciences Management, Inc. |
Treatment of fragile x syndrome with cannabidiol
|
|
GB201715919D0
(en)
|
2017-09-29 |
2017-11-15 |
Gw Res Ltd |
use of cannabinoids in the treatment of epilepsy
|
|
SG11202003505RA
(en)
|
2017-10-17 |
2020-07-29 |
Remy Biosciences Inc |
Improved delivery systems for moieties including cbd enhanced combinations, formulations and chimeras
|
|
US10307392B2
(en)
|
2017-10-21 |
2019-06-04 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
ES3064839T3
(en)
|
2017-11-15 |
2026-04-29 |
The Regents Of The Univ Of California |
Combination of cannabidiol and buprenorphine and its use for the treatment of chronic pain
|
|
WO2019130215A1
(en)
|
2017-12-27 |
2019-07-04 |
To Pharmaceuticals Llc |
Cannabis compositions for the treatment of inflammatory skin disorders
|
|
US10722545B2
(en)
|
2018-01-01 |
2020-07-28 |
Alexander Kariman |
Compound and method for treatment of movement disorders
|
|
GB2572126B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
BR112020014253A2
(pt)
*
|
2018-01-12 |
2020-12-08 |
Nutrae, LLC |
Formulações de canabinóides encapsuladas para administração oral
|
|
US11759473B2
(en)
|
2018-02-16 |
2023-09-19 |
American Nano, LLC |
Topical compositions incorporating silica fibers
|
|
EP3755372A1
(en)
|
2018-02-23 |
2020-12-30 |
Nicola Michael Spirtos |
Cannabis based therapeutic and method of use
|
|
EP4252778A3
(en)
|
2018-04-04 |
2023-10-18 |
Vinsan Therapeutics Inc. |
Topical cannabinoid formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
|
|
WO2019198056A1
(en)
|
2018-04-14 |
2019-10-17 |
Buzzelet Development And Technologies Ltd |
Terpene-enriched cannabinoid composition for treating conditions and/ or symptoms associated with a stressful event
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
BR112020021966A2
(pt)
|
2018-04-27 |
2021-01-26 |
Remy Biosciences, Inc. |
dispositivos médicos, veículos de liberação e fabricação dos mesmos
|
|
US20190328884A1
(en)
|
2018-04-30 |
2019-10-31 |
Chemic Laboratories, Inc. |
Compositions and methods of their use
|
|
WO2019224824A1
(en)
|
2018-05-24 |
2019-11-28 |
To Pharmaceuticals Llc |
Cannabis-based compositions for the treatment of autistic spectrum disorders
|
|
US10864189B2
(en)
|
2018-06-29 |
2020-12-15 |
Jenna Borok |
Topical compositions comprising polyolprepolymers, stem cell, and cannabinoids for skin care
|
|
GB201811834D0
(en)
|
2018-07-19 |
2018-09-05 |
Medherant Ltd |
Patch
|
|
GB201811833D0
(en)
|
2018-07-19 |
2018-09-05 |
Medherant Ltd |
Patch
|
|
US20200054887A1
(en)
|
2018-08-15 |
2020-02-20 |
Bruce H. Levin |
Topical Therapeutics
|
|
US10751299B2
(en)
|
2018-09-04 |
2020-08-25 |
Babak Ghalili |
Cannabinoid and menthol compositions and methods
|
|
CA3060926A1
(en)
|
2018-09-06 |
2020-03-06 |
NuVessl, Inc. |
Method of using cannabinoids encapsulated in phospholipid carriers for transmucosal and transdermal administration
|
|
IL261774B
(en)
|
2018-09-13 |
2020-04-30 |
Unv Medicine Ltd |
Preparations for the treatment of skin problems
|
|
US11357958B2
(en)
|
2018-10-25 |
2022-06-14 |
Medtronic Vascular, Inc. |
Devices and techniques for cardiovascular intervention
|
|
WO2020115751A1
(en)
|
2018-12-06 |
2020-06-11 |
To Pharmaceuticals Llc |
Cannabis-based compositions for the treatment of alzheimer's disease and dementia
|
|
CA3122994A1
(en)
|
2018-12-11 |
2020-06-18 |
The Regents Of The Universtiy Of Michigan |
Co-crystals, method and apparatus for forming the same
|
|
CA3122735A1
(en)
|
2018-12-14 |
2020-06-18 |
Zynerba Pharmaceuticals, Inc. |
Treatment of 22q11.2 deletion syndrome with cannabidiol
|
|
EP3902553A4
(en)
|
2018-12-27 |
2022-10-05 |
Buzzelet Development And Technologies Ltd |
HERB-INFUSED CANNABINOID COMPOSITION AND METHODS OF TREATMENT
|
|
AU2019413789B2
(en)
|
2018-12-29 |
2025-05-29 |
Buzzelet Development And Technologies Ltd. |
Isolated or synthetic cannabinoid compositions with selected terpene blend and methods of use thereof
|
|
EP3906025A4
(en)
|
2019-01-04 |
2022-09-21 |
Columbia Care LLC |
CANNABINOID TOPICAL FORMULATIONS
|
|
GB2580653A
(en)
|
2019-01-21 |
2020-07-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of comorbidities associated with epilepsy
|
|
WO2020157639A1
(en)
|
2019-01-29 |
2020-08-06 |
Buzzelet Development And Technologies Ltd. |
Terpene-enriched cannabinoid composition and method of treatment for treating conditions and/or symptoms associated with autism spectrum disorder
|
|
MA54877A
(fr)
|
2019-01-30 |
2021-12-08 |
Diamond Therapeutics Inc |
Compositions et méthodes comprenant un agoniste de récepteur 5ht destinées au traitement de troubles psychologiques, cognitifs, comportementaux et/ou d'humeur
|
|
US20210015740A1
(en)
|
2019-03-04 |
2021-01-21 |
Michael Harvey Greenspan |
Topical cannabinoid compositions, delivery systems, and uses for pain relief
|
|
EP3934641A4
(en)
|
2019-03-07 |
2022-12-21 |
Ilera Therapeutics LLC |
FORMULATIONS FOR THE TREATMENT OF SYMPTOMS ACCOMPLISHED WITH AUTISM
|
|
WO2020183350A1
(en)
|
2019-03-12 |
2020-09-17 |
Radient Technologies Innovations Inc. |
Transdermal patch kit with transdermal dosage units
|
|
EA202192334A1
(ru)
|
2019-03-26 |
2022-02-08 |
Винсантор, Инк. |
Составы для местного применения для лечения периферических невропатий
|
|
CA3135877A1
(en)
|
2019-04-03 |
2020-10-08 |
Ely Nigel STRATEMEYER-TRINCZEK |
Transdermal medicament
|
|
US20200330379A1
(en)
|
2019-04-17 |
2020-10-22 |
Navinta NV, Inc. |
Non-oral cannabinoid formulation and method of treatment
|
|
WO2020220092A1
(en)
|
2019-05-01 |
2020-11-05 |
Cannadol Pharmaceuticals |
Compositions and methods for pain and anxiety relief
|
|
US20200345685A1
(en)
|
2019-05-02 |
2020-11-05 |
Christopher Ayo Otiko |
Topical application of medical cannabis
|
|
US20200345653A1
(en)
|
2019-05-02 |
2020-11-05 |
Kenda Hansen |
Transdermal Composition
|
|
WO2020220141A1
(en)
|
2019-05-02 |
2020-11-05 |
Betterlife Pharma Inc. |
Cannabinoid stock transdermal formulations
|
|
US20200352849A1
(en)
|
2019-05-07 |
2020-11-12 |
Adam M. Rotunda |
Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment
|
|
EP3975703A4
(en)
|
2019-05-28 |
2023-07-12 |
Tech Swerve LLC |
PENETRATING TOPICAL PAIN RELIEF COMPOSITIONS AND METHOD OF USE
|
|
US11026896B2
(en)
|
2019-06-18 |
2021-06-08 |
Dyve Biosciences, Inc. |
Transdermal penetrant formulations containing cannabidiol
|
|
US10588871B1
(en)
|
2019-06-28 |
2020-03-17 |
Nexzol Pharma, Inc. |
Transdermal formulation for the treatment of pain and/or inflammation
|
|
CN114727970A
(zh)
|
2019-07-02 |
2022-07-08 |
艾乐文特科学公司 |
用于治疗动物中的疼痛、癌症和癫痫的大麻提取物
|
|
US20220304980A1
(en)
|
2019-07-04 |
2022-09-29 |
SW Holdings, Inc |
Metered dosing compositions and methods of use of psychedelic compounds
|
|
KR20220044558A
(ko)
|
2019-08-05 |
2022-04-08 |
씨에스 메디카 에이/에스 |
칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도
|
|
WO2021050429A1
(en)
|
2019-09-10 |
2021-03-18 |
Pureform Global, Inc. |
Topical composition for treatment of pain
|
|
BR112022004175A2
(pt)
|
2019-09-17 |
2022-05-31 |
Zynerba Pharmaceuticals Inc |
Tratamento de encefalopatia de syngap1
|
|
US11951079B2
(en)
|
2019-10-03 |
2024-04-09 |
Kongkrit Chaiyasate |
Topical cannabidiol composition
|
|
CA3155181A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
US11318093B2
(en)
|
2019-11-08 |
2022-05-03 |
Pac-Dent, Inc. |
Dental topical anesthetic gel
|
|
US20210145764A1
(en)
|
2019-11-15 |
2021-05-20 |
Brigham Young University |
Compositions of cannabidiol (cbd), and/or polyphenols, and methods for the prevention and/or treatment of skin, muscle, nerve and inflammatory disorders, and biological factors and functions in mammals
|
|
WO2021102353A1
(en)
|
2019-11-20 |
2021-05-27 |
Canole Llc |
Combination cannabinoid-nad+ precursor formulation for treatment of inflammation and methods related thereto
|
|
US20210244680A1
(en)
|
2020-02-10 |
2021-08-12 |
Ghassan S. Kassab |
Wearable liposomal cannabidiol transdermal patch
|
|
CA3170545A1
(en)
|
2020-02-11 |
2021-08-19 |
Babak Ghalili |
Cannabinoid and menthol transdermal delivery systems and methods
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
WO2021177937A1
(en)
|
2020-03-02 |
2021-09-10 |
Babak Ghalili |
Cannabinoid and menthol compositions and methods
|
|
WO2021177940A1
(en)
|
2020-03-03 |
2021-09-10 |
Babak Ghalili |
Cannabinoid and menthol gel compositions, patches and methods
|
|
CA3178878A1
(en)
|
2020-04-20 |
2021-10-28 |
Fotios M. Plakogiannis |
Transdermal and/or topical pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic pain
|
|
WO2021236782A1
(en)
|
2020-05-19 |
2021-11-25 |
Mig Usa, Llc |
Topical compositions and methods for treating pain
|
|
WO2022003623A1
(en)
|
2020-07-01 |
2022-01-06 |
Pike Therapeutics, Inc. |
Transdermal pharmaceutical formulations for the treatment of multiple sclerosis
|
|
US20220047525A1
(en)
|
2020-08-17 |
2022-02-17 |
Pike Therapeutics, Inc. |
Transdermal pharmaceutical formulations of nabilone alone and in combination with cannabinoids
|
|
CN117337174A
(zh)
|
2020-12-03 |
2024-01-02 |
长矛治疗股份有限公司 |
用于治疗癌症的包含cbd或thc的透皮药物制剂
|